Excellent entry point for SYN after move from Golden Cross
Expect this stock to move upwards.
SYN, is displaying a descending triangle off of a big move and has support at 2.30.
As highlighted on Bulkwoski's site (thepatternsite.com/dt.html): "If price rises into the pattern it breaks out upward 73% of the time."
This company 4 drugs ... one which has shown to improve MS patients, and another which address C Diff. C Diff has been declared by the CDC as in need of national focus. Shortly afterwards, C Diff caused Toronto's largest hospital to shut down a part of its cardiovascular unit. news.nationalpost.com/2015/02/11/torontos-largest-hospital-shuts-down-part-of-cardiovascular-unit-after-c-difficile-outbreak/. SYN is the only company to have a drug in the pipe that address C Diff.
This seeking alpha article does an excellent job summing up the potential in more depth for the pipeline.
seekingalpha.com/article/2902236-synthetic-biologics-a-speculative-small-cap-packed-with-power
This link from the SYN site, nicely sums up the pipeline:
syntheticbiologics.com/index.php?s=99
Overall, this company is extremely undervalued and is primed for huge moves over the next several weeks as news of it's MS drug comes out.
SYN, is displaying a descending triangle off of a big move and has support at 2.30.
As highlighted on Bulkwoski's site (thepatternsite.com/dt.html): "If price rises into the pattern it breaks out upward 73% of the time."
This company 4 drugs ... one which has shown to improve MS patients, and another which address C Diff. C Diff has been declared by the CDC as in need of national focus. Shortly afterwards, C Diff caused Toronto's largest hospital to shut down a part of its cardiovascular unit. news.nationalpost.com/2015/02/11/torontos-largest-hospital-shuts-down-part-of-cardiovascular-unit-after-c-difficile-outbreak/. SYN is the only company to have a drug in the pipe that address C Diff.
This seeking alpha article does an excellent job summing up the potential in more depth for the pipeline.
seekingalpha.com/article/2902236-synthetic-biologics-a-speculative-small-cap-packed-with-power
This link from the SYN site, nicely sums up the pipeline:
syntheticbiologics.com/index.php?s=99
Overall, this company is extremely undervalued and is primed for huge moves over the next several weeks as news of it's MS drug comes out.
相關出版品
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。